FDA Brief

Warning letters Food

FDA warning letter to

AusarHerbs

High riskIssued Jan 12, 2021Posted Jan 27, 2021Center for Food Safety and Applied Nutrition (CFSAN)

AusarHerbs sold Corona Destroyer Tea with COVID-19 prevention and reversal claims as an unapproved, misbranded drug.

What happened

FDA reviewed ausarherbs.com on December 17, 2020, and FTC reviewed it on December 21, 2020. The site sold “Corona Destroyer Tea” in “Prevention” and “Reversal” options and claimed it would prevent or destroy COVID-19, reverse it in 7 days, and clear symptoms in 3 days. FDA cited it as an unapproved new drug and a misbranded drug.

What FDA found

  1. The company sold a product as a new drug without FDA approval.

    section 505(a) of the FD&C Act, 21 U.S.C. § 355(a)
  2. The product was misbranded because its labeling made COVID-19 drug claims.

    section 502 of the FD&C Act, 21 U.S.C. § 352
  3. The company introduced the product into interstate commerce despite these violations.

    sections 301(a) and (d) of the FD&C Act, 21 U.S.C. § 331(a) and (d)
  4. The company advertised that the tea could prevent, treat, or cure COVID-19 without competent and reliable scientific evidence.

    FTC Act, 15 U.S.C. 41 et seq.

What FDA wants

Immediately stop selling any unapproved or unauthorized products claimed to prevent, treat, diagnose, or cure COVID-19. Within 48 hours, email FDA and FTC with the specific steps taken and documentation; if unable to act completely, explain the delay and when you will comply.

Who should pay attention

  • herbal and tea brands making health claims
  • online sellers of COVID-19-related products
  • retailers or marketplaces listing unapproved disease treatments

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk